. Organization and . Wh, GLobal tuberculosis control: epidemiology, strategy, financing, 2009.

N. Yamada, K. Saorith, K. Yamakami, I. Onozaki, S. Boran et al., The national tuberculosis drug resistance survey in Cambodia, Int J Tuberc Lung Dis, issue.12, pp.111321-1327, 2000.

B. Sar, C. Keo, C. Leng, M. Saman, D. Min et al., Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health, vol.40, issue.1, pp.104-107, 2009.

J. Kamerbeek, L. Schouls, A. Kolk, M. Van-agterveld, D. Van-soolingen et al., Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, vol.35, issue.4, pp.907-914, 1997.

J. Sekiguchi, T. Miyoshi-akiyama, E. Augustynowicz-kopec, Z. Zwolska, F. Kirikae et al., Detection of Multidrug Resistance in Mycobacterium tuberculosis, Journal of Clinical Microbiology, vol.45, issue.1, pp.179-192, 2007.
DOI : 10.1128/JCM.00750-06

S. Sreevatsan, X. Pan, K. Stockbauer, N. Connell, B. Kreiswirth et al., Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination, Proceedings of the National Academy of Sciences, vol.94, issue.18, pp.949869-9874, 1997.
DOI : 10.1073/pnas.94.18.9869

F. Minime-lingoupou, C. Pierre-audigier, E. Kassa-kelembho, N. Barilone, G. Zandanga et al., Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic, Int J Tuberc Lung Dis, vol.14, issue.6, pp.782-785
URL : https://hal.archives-ouvertes.fr/pasteur-00540451

H. Ando, S. Mitarai, Y. Kondo, T. Suetake, J. Sekiguchi et al., Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan, Clinical Microbiology and Infection, vol.16, issue.8, pp.1164-1168
DOI : 10.1111/j.1469-0691.2009.03078.x

G. Louw, R. Warren, P. Donald, M. Murray, M. Bosman et al., Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients, Int J Tuberc Lung Dis, issue.7, pp.10802-807, 2006.

P. Riska, W. Jacobs, . Jr, and D. Alland, Molecular determinants of drug resistance in tuberculosis, Int J Tuberc Lung Dis, vol.4, issue.2, 2000.

H. Zhang, L. Bi, C. Li, Z. Sun, J. Deng et al., in Clinical Pyrazinamide-resistant Isolates from a Local Region of China, Journal of International Medical Research, vol.275, issue.5, pp.1430-1435, 2009.
DOI : 10.1177/147323000903700517

M. Zignol, M. Hosseini, A. Wright, C. Weezenbeek, P. Nunn et al., Global Incidence of Multidrug???Resistant Tuberculosis, The Journal of Infectious Diseases, vol.194, issue.4, pp.479-485, 2006.
DOI : 10.1086/505877

C. Xu, B. Kreiswirth, S. Sreevatsan, J. Musser, and K. Drlica, Fluoroquinolone Resistance Associated with Specific Gyrase Mutations in Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis, Journal of Infectious Diseases, vol.174, issue.5, pp.1127-1130, 1996.
DOI : 10.1093/infdis/174.5.1127

T. Kocagoz, C. Hackbarth, I. Unsal, E. Rosenberg, H. Nikaido et al., Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra, Antimicrob Agents Chemother, issue.8, pp.401768-1774, 1996.

T. Huang, C. Kunin, S. Lee, S. Chen, Y. Tu et al., Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003, Journal of Antimicrobial Chemotherapy, vol.56, issue.6, pp.561058-1062, 2005.
DOI : 10.1093/jac/dki353

P. Xu, X. Li, M. Zhao, X. Gui, K. Deriemer et al., Prevalence of Fluoroquinolone Resistance among Tuberculosis Patients in Shanghai, China, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.533170-3172, 2009.
DOI : 10.1128/AAC.00177-09

F. Brossier, N. Veziris, V. Jarlier, and W. Sougakoff, Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid, Int J Tuberc Lung Dis, vol.13, issue.2, pp.260-265, 2009.

E. Grimaldo, T. Tupasi, A. Rivera, M. Quelapio, R. Cardano et al., Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines, Int J Tuberc Lung Dis, vol.5, issue.6, pp.546-550, 2001.

L. Bozeman, W. Burman, B. Metchock, L. Welch, and M. Weiner, Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada, Clinical Infectious Diseases, vol.40, issue.3, pp.386-391, 2005.
DOI : 10.1086/427292

Y. Balabanova, R. M. Hubb, J. Yates, M. Malomanova, N. Fedorin et al., Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy, European Journal of Clinical Microbiology & Infectious Diseases, vol.124, issue.2, pp.136-139, 2005.
DOI : 10.1007/s10096-004-1268-4

D. Hillemann, S. Rusch-gerdes, and E. Richter, Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens, Journal of Clinical Microbiology, vol.47, issue.6, pp.471767-1772, 2009.
DOI : 10.1128/JCM.00081-09

V. Kiet, N. Lan, D. An, N. Dung, D. Hoa et al., Evaluation of the MTBDRsl Test for Detection of Second-Line-Drug Resistance in Mycobacterium tuberculosis, Journal of Clinical Microbiology, vol.48, issue.8, pp.2934-2939
DOI : 10.1128/JCM.00201-10

M. Goble, M. Iseman, L. Madsen, D. Waite, L. Ackerson et al., Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin, New England Journal of Medicine, vol.328, issue.8, pp.527-532, 1993.
DOI : 10.1056/NEJM199302253280802

E. Telzak, K. Sepkowitz, P. Alpert, S. Mannheimer, F. Medard et al., Multidrug-Resistant Tuberculosis in Patients without HIV Infection, New England Journal of Medicine, vol.333, issue.14, pp.333907-911, 1995.
DOI : 10.1056/NEJM199510053331404

M. Conde, A. Efron, C. Loredo, D. Souza, G. Graca et al., Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial, The Lancet, vol.373, issue.9670, pp.3731183-1189, 2009.
DOI : 10.1016/S0140-6736(09)60333-0

R. Rustomjee, C. Lienhardt, T. Kanyok, G. Davies, J. Levin et al., A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis, Int J Tuberc Lung Dis, vol.12, issue.2, pp.128-138, 2008.

S. Moadebi, C. Harder, M. Fitzgerald, K. Elwood, and F. Marra, Fluoroquinolones for the Treatment of Pulmonary Tuberculosis, Drugs, vol.169, issue.3, pp.2077-2099, 2007.
DOI : 10.2165/00003495-200767140-00007

J. Wang, L. Lee, H. Lai, S. Wang, I. Jan et al., Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure, Journal of Antimicrobial Chemotherapy, vol.59, issue.5, pp.59860-865, 2007.
DOI : 10.1093/jac/dkm061

M. Yu, M. Wu, and R. Jou, Extensively Drug-Resistant Tuberculosis,Taiwan, Emerging Infectious Diseases, vol.14, issue.5, pp.849-850, 2008.
DOI : 10.3201/eid1405.071398
URL : http://doi.org/10.3201/eid1405.071398

Z. Udwadia, S. Jain, C. Rodrigues, and A. Mehta, XDR tuberculosis in India: what's in a name?, The Lancet Infectious Diseases, vol.7, issue.7, pp.441-442, 2007.
DOI : 10.1016/S1473-3099(07)70141-X

I. Mokrousov, I. Filliol, E. Legrand, C. Sola, T. Otten et al., Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene, Research in Microbiology, vol.153, issue.4, pp.213-219, 2002.
DOI : 10.1016/S0923-2508(02)01311-6

I. Mokrousov, O. Narvskaya, T. Otten, E. Limeschenko, L. Steklova et al., High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, Antimicrob Agents Chemother, issue.5, pp.461417-1424, 1996.

I. Mokrousov, T. Otten, A. Vyazovaya, E. Limeschenko, M. Filipenko et al., PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia, Eur J Clin Microbiol Infect Dis, issue.6, pp.22342-348, 2003.